CirrusMD Secures $15 Million Series B Funding to Enhance Its Virtual Care Platform and Expand Telehealth Services

VCBeat (WeChat Official Account: vcbeat) learned from foreign media that on May 2, U.S. local time, healthcare technology company CirrusMD completed a $15 million Series B financing round. The funds from this round will be used to advance the development of the company’s information-based healthcare platform, reduce healthcare costs, and provide patients with efficient and comprehensive medical services.

It is reported that this round of financing was led by Drive Capital, with participation from Colorado Impact Fund.

CirrusMD, founded in 2012 and headquartered in Colorado, USA, is a healthcare technology company focused on developing an information-based diagnosis and treatment platform. The company is committed to addressing issues such as unequal distribution of medical resources and low diagnostic and treatment efficiency, helping patients access medical services online.

The CirrusMD Signature platform is the flagship product of CirrusMD Inc., featuring the following key functionalities: (1) Immediate Access: Patients can register for a private account on the company’s official website at any time. Without any additional steps, they can initiate video consultations with physicians and receive medical care immediately after registration; (2) Flexible Selection: The CirrusMD Signature platform aggregates comprehensive profiles of licensed physicians across various medical specialties. Patients can select specific categories, review physician credentials, and flexibly choose the most suitable provider. This model not only eliminates the awkwardness often associated with selecting doctors in traditional hospital settings but also enables patients to access higher-quality care at a lower cost; (3) Comprehensive Service: Medical services provided through the CirrusMD Signature platform are governed by timelines determined by the patient. In traditional offline healthcare institutions, patients may experience delays or forced interruptions in treatment due to shortages of physician resources or medical equipment. CirrusMD empowers patients by granting them control over the care process: once a connection is established between a physician and a patient, the consultation service cannot be terminated until the patient confirms full recovery. This ensures the effectiveness of medical treatment and provides robust safeguards for patients; (4) Multimedia Information Transmission: The CirrusMD Signature platform not only connects patients with physicians but also supports the upload of relevant diagnostic information, such as X-rays. This approach facilitates more scientific disease diagnosis by physicians, reduces medical expenses for patients, and enhances overall healthcare efficiency.

Moly McCartin, Partner at Drive Capital, stated, “Today’s healthcare system is imperfect, with inefficient consultations and insufficient medical resources being urgent issues to address. The new consultation platform provided by CirrusMD integrates multiple medical institutions, enabling efficient patient consultations and addressing the industry’s most pressing needs. We are very optimistic about CirrusMD’s development prospects.”

Andrew Altorfer, CEO and Co-Founder of CirrusMD, stated, “We are grateful for the support from our new round of investors. We will utilize this financing to enhance our platform for integrating medical resources. Currently, we have established partnerships with healthcare institutions across all 50 U.S. states, striving to provide patients with more efficient and comprehensive services while reducing healthcare costs.”

Drive Capital, founded in 2013 and headquartered in Ohio, USA, is a venture capital firm that focuses on investing in the early-stage development of startups in the biomedical sector. Its primary investment geographic scope is the Midwestern United States, and it has completed 37 investments to date. In addition to providing financial support to life sciences startups, the firm leverages its extensive market resources to help entrepreneurs manage and grow their companies, as well as expand their market share.

Colorado Impact Fund, established in 2014, is a venture capital firm headquartered in Colorado, United States. The firm focuses on investing in early-stage companies in the life sciences sector and has completed 13 investments to date.

(Compiled by Liu Yujing)